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Abstract
Background: Intrinsic factors and extrinsic signals which control unlimited self-renewal and developmental
pluripotency in embryonic stem cells (ESCs) have been extensively investigated. However, a much smaller number
of factors involved in extra-embryonic trophoblast differentiation from ESCs have been studied. In this study, we
investigated the role of the single-stranded DNA binding protein, Ssbp3, for the induction of trophoblast-like
differentiation from mouse ESCs.
Methods: Gain- and loss-of-function experiments were carried out through overexpression or knockdown of Ssbp3
in mouse ESCs under self-renewal culture conditions. Expression levels of pluripotency and lineage markers were
detected by real-time quantitative reverse-transcription polymerase chain reaction (qRT-PCR) analyses. The global
gene expression profile in Ssbp3-overexpressing cells was determined by affymetrix microarray. Gene ontology and
pathway terms were analyzed and further validated by qRT-PCR and Western blotting. The methylation status of
the Elf5 promoter in Ssbp3-overexpressing cells was detected by bisulfite sequencing. The trophoblast-like
phenotype induced by Ssbp3 was also evaluated by teratoma formation and early embryo injection assays.
Results: Forced expression of Ssbp3 in mouse ESCs upregulated expression levels of lineage-associated genes, with
trophoblast cell markers being the highest. In contrast, depletion of Ssbp3 attenuated the expression of trophoblast
lineage marker genes induced by downregulation of Oct4 or treatment with BMP4 and bFGF in ESCs. Interestingly,
global gene expression profiling analysis indicated that Ssbp3 overexpression did not significantly alter the
transcript levels of pluripotency-associated transcription factors. Instead, Ssbp3 promoted the expression of early
trophectoderm transcription factors such as Cdx2 and activated MAPK/Erk1/2 and TGF-β pathways. Furthermore,
overexpression of Ssbp3 reduced the methylation level of the Elf5 promoter and promoted the generation of
teratomas with internal hemorrhage, indicative of the presence of trophoblast cells.
Conclusions: This study identifies Ssbp3, a single-stranded DNA binding protein, as a regulator for mouse ESCs to
differentiate into trophoblast-like cells. This finding is helpful to understand the regulatory networks for ESC
differentiation into extra-embryonic lineages.
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Background
The formation of the early blastocyst represents the first
lineage specification of mammalian embryos. At this
stage, the mammalian embryo forms an internal cavity,
and contains two types of cells: the inner cell mass
(ICM) growing on the interior and the monolayer of the
trophectoderm (TE) growing on the exterior [1, 2]. The
ICM possesses developmental pluripotency, and de-
velops into the three germ layers as well as the extra-
embryonic mesoderm portion of the placenta, while the
TE gives rise to the extra-embryonic ectoderm portion
of the placenta [3].
Embryonic stem cells (ESCs) and trophoblast stem
cells (TSCs) are cell culture derivatives of the ICM and
TE, respectively [4, 5]. These two stem cell types possess
distinctly different abilities to self-renew and generate
progenies, which are under the control of both extrinsic
signals and intrinsic regulatory networks. Although de-
rived from the ICM, ESCs can undergo trans-differenti-
ation towards extra-embryonic trophoblast lineage via
overexpression of TE master regulators, such as Cdx2
and Gata3 [6–8]. In contrast to the extensive studies on
the molecular regulation of ESC self-renewal and pluri-
potency, only a few of the factors involved in extra-
embryonic lineage differentiation of ESCs have been
defined.
Ssbp3 (single-stranded DNA binding protein 3) be-
longs to a family of single-stranded DNA binding pro-
teins which recognizes pyrimidine-rich single-stranded
DNA and regulates transcription. It has two homo-
logues, Ssbp2 and Ssbp4 [9]. In 1998, Bayarsaihan et al.
discovered that Ssbp3 could bind a conserved sequence,
containing pyrimidines almost exclusively, on one strand
in chicken collagen α2 (I) promoter regions to regulate
its expression [10]. Further studies revealed the function
of Ssbp3 in regulating mouse head morphogenesis by
protecting Ldb1 from Rlim-mediated ubiquitination in
development. Ssbp3 null mice lacked the head structure
from the anterior to the ear, accompanied by a small size
and spine deformity [11–16]. However, the function of
Ssbp3 in early embryonic and extra-embryonic develop-
ment remains unknown.
In the present study, we report that Ssbp3 plays an im-
portant role in regulating mouse ESC differentiation to
trophoblast-like cells. We show that the expression of
Ssbp3 was increased in ESC differentiation models to-
wards trophoblast lineages induced by either Oct4
downregulation or supplementation of bone morpho-
genetic protein (BMP)4 and basic fibroblast growth fac-
tor (bFGF). Forced expression of Ssbp3 substantially
promoted differentiation. The cells overexpressing Ssbp3
had gene expression patterns resembling those of
trophoblast cells and formed teratomas containing hem-
orrhages in vivo. In contrast, depletion of Ssbp3
compromised the induction of trophoblast differenti-
ation from ESCs. Genome-wide gene expression analysis
indicated that Ssbp3 overexpression in ESCs activated
mitogen-activated protein kinase (MAPK)/extracellular
signal-regulated kinase (Erk)1/2 and transforming
growth factor (TGF)-β pathways, which are known to be
critical for mouse trophoblast development [17–20], and
induced the expression of trophoblast lineage-associated
markers. Taken together, our results revealed that Ssbp3
played an important role in the control of ESCs to differ-
entiate into trophoblast-like cells.
Methods
Cell culture
Mouse E14T and ZHBTc4 ESCs (kind gifts from Dr.
Austin Smith) were cultured under feeder-free conditions
in GMEM (Glasgow's minimum essential medium; Invi-
trogen) supplemented with 10 % fetal bovine serum (FBS;
Hyclone), 1 mM sodium pyruvate (Sigma), 0.1 mM
non-essential amino acids (NEAA; Invitrogen), 2 mM
L-glutamine (Invitrogen), 100 μM β-mercaptoethanol
(Invitrogen), 100 U/mL penicillin and 100 μg/mL
streptomycin (Hyclone), and 1000 U/mL recombinant
leukemia inhibitory factor (LIF; Chemicon).
Mouse TSCs (a kind gift from Dr. Shaorong Gao) were
maintained in the medium containing 30 % TS medium
and 70 % mouse embryonic fibroblast (MEF)-condi-
tioned TS medium with 25 ng/mL human recombinant
fibroblast growth factor 4 (FGF4; Invitrogen) and 1 μg/mL
heparin (Sigma) in 0.1 % gelatin-coated dishes. In detail,
the TSC medium based on RPMI 1640 (Invitrogen) was
supplemented with 20 % FBS (Hyclone), 1 mM sodium
pyruvate (Sigma), 2 mML-glutamine (Invitrogen), 100 μM
β-mercaptoethanol (Invitrogen), and 100 U/mL penicillin
and 100 μg/mL streptomycin (Hyclone) [21].
MEF and 293T cells were cultured in Dulbecco's modi-
fied Eagle’s medium (DMEM; Invitrogen) with 10 % FBS
(Hyclone), and 100 U/mL penicillin and 100 μg/mL
streptomycin (Hyclone) [22].
The trophoblast induction medium was modified based
on the TX medium [23], and contained the KnockOut
DMEM/F-12 (Invitrogen), 64 μg/mL L-ascorbic acid-2-
phosphate magnesium (ACC), insulin-transferrin-selenium
(Life Technologies), 543 μg/mL NaHCO3 (Sigma), 1 μg/mL
heparin (Sigma), 2 mML-glutamine (Life Technologies),
100 U/mL penicillin and 100 μg/mL streptomycin
(Hyclone), 10 ng/mL BMP4 (HUMANZYME), and
25 ng/mL bFGF (HUMANZYME).
Plasmids and antibodies
The coding sequences of full length Ssbp3 [NCBI Refer-
ence Sequence: NM_023672.2], its truncations, and full
length Cdx2 [NCBI Reference Sequence: NM_007673.3]
were amplified by polymerase chain reaction (PCR) from
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complementary DNA (cDNA) of mouse ESCs or TSCs,
respectively. PCR products were inserted into the pPy-
CAGIP expression vector (a kind gift from Dr. Ian
Chambers). Primers used for gene cloning are listed in
Additional file 1 (Table S1). Lentiviral vector pLKO.1-
hygro (Addgene) was used to express short-hairpin
RNAs (shRNAs) that targeted mouse Ssbp3, Cdx2, or
Gata3 mRNA, respectively [24]. For lentiviral packaging,
psPAX2 and pMD2.G vectors (kind gifts from Dr. Didier
Trono) were used. shRNA targeting sequences are also
listed in Additional file 1 (Table S1). The inserted se-
quences and ligation sites of all constructs were vali-
dated by DNA sequencing. Western blotting was carried
out with primary antibodies against Ssbp3 (Genetex),
Cdx2 (Biogenex), Oct4 (produced and affinity-purified in
our laboratory), phospho-Erk1/2 (Cell Signaling Tech-
nology), total Erk1/2 (Cell Signaling Technology), and β-
Tubulin (Sigma). For immunofluorescence staining, cells
were incubated with primary antibody against Cdx2
(Biogenex) and then Cy3 conjugated goat anti-mouse
secondary antibody (ProteinTech Group).
Transfection and infection
Mouse ESCs were plated in six-well plates at a density
of 1.0 × 105 cells per well. Twenty-four hours later, cells
were transfected with plasmids via Lipofectamine™2000
(Invitrogen), or infected with viral particles.
Western blotting
Proteins extracted from the indicated cells were sub-
jected to Western blotting with the amount of 100 μg
proteins per lane, as described previously [25].
Immunofluorescence staining
Mouse ESCs were plated in four-well plates containing
coverslips at a density of 1.0 × 105 cells per well and
were transfected with an empty vector or an Ssbp3 ex-
pression plasmid on the second day, respectively. The
cells were cultured at 37 °C for an additional 96 h. They
were then fixed with 4 % paraformaldehyde for 15 min,
permeabilized with 0.2 % Triton X-100 for 10 min, and
blocked with 3 % bovine serum albumin (BSA) for
30 min. Next, cells were incubated with the primary
anti-Cdx2 antibody (1:500 diluted) overnight at 4 °C.
The next day, cells were incubated with the fluorescent
Cy3-goat anti-mouse antibody (1:200 diluted) for 1 h at
room temperature in the dark. The nuclei were further
stained with 4',6-diamidino-2-phenylindole (DAPI; Invitro-
gen) for 3 min. Finally, coverslips were dried and affixed to
slides using a fluorescent mounting medium [26].
qRT-PCR analyses
Total RNA was extracted and transcribed into cDNA as
previously described [27]. GAPDH was used to normalize
gene expression levels in cells, and 28S rRNA was used as
an internal control in teratoma analysis. Real-time quanti-
tative reverse transcription PCR (qRT-PCR) analyses were
performed on an ABI7900 using the FastStart Universal
SYBR Green Master (Roche) as previously described [27].
Primers used for qRT-PCR analyses are listed in Add-
itional file 1 (Table S1).
Microarray assay and data analysis
Mouse ESC samples transfected with an empty vector or
an Ssbp3 expression plasmid for 96 h were collected for
gene expression detection using the Affymetrix GeneChip®
Mouse Genome 430 2.0 Array. Duplicate samples were
subjected to array analysis. The procedures including
RNA extraction, cDNA synthesis, labeling, hybridization,
washing, and scanning were performed by the Shanghai
Biotechnology Corporation. Datasets were submitted to
the database for annotation, visualization, and integrated
discovery (DAVID), and analyzed by gene ontology (GO)
analysis and Kyoto encyclopedia of genes and genomes
(KEGG) pathway mapping. Data are publically available at
the National Center for Biotechnology Information with
Gene Expression Omnibus accession number GSE67562.
Bisulfite sequencing
The bisulfite treatment of DNA was performed using
the EZ-DNA methylation direct kit (Zymo Research) ac-
cording to the manufacturer’s instructions. Elf5 primers
were the same as described previously [28]. Amplified
products were purified using gel filtration columns,
cloned into the pGEM-T Easy Vector (Promega), and se-
quenced using SP6 primers. For each promoter se-
quence, ten randomly selected clones were sequenced.
Teratomas
Mouse ESCs transfected with an empty vector or an
Ssbp3 expression plasmid were selected with 1 μg/mL
puromycin (Sigma) for 48 h. Then 1.5 × 106 cells were
intramuscularly injected into NOD/SCID mice [29].
Teratomas were collected 6 weeks later for qRT-PCR de-
tection of gene expression and histological analysis.
Chimera
Mouse ESCs constitutively expressing the H2B-GFP fu-
sion gene were transfected with a vector or an Ssbp3 ex-
pression plasmid. Twenty-four hours later, cells were
selected with 1 μg/mL puromycin for 2 days. Two cells
were injected into each 8-cell-stage mouse embryo. The
embryos were subsequently transferred into the uterus
of pseudo-pregnant female mice following standard pro-
cedures. Injected embryos at embryonic day 6.5 (E6.5)
and E14.5 were collected and imaged, respectively.
Fluorescence images were taken by a laser confocal
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scanning microscope (Zeiss, LSM710) or a stereo zoom
microscope (Zeiss, Axio Zoom.V16).
Statistical analysis
All data were from three biological replicates and are
presented as means ± SD. Pairwise statistical significance
was determined by the Student’s t test. p < 0.05 was con-
sidered statistically significant.
Results
Forced expression of Ssbp3 induces differentiation of
mouse ESCs with a trophoblast-like gene expression
pattern
To study the function of Ssbp3 in mouse ESCs, we over-
expressed Ssbp3 in E14T ESCs cultured under a self-
renewal condition, in parallel with an empty vector as a
negative control (Fig. 1a). Obvious differentiation was
observed 96 h after transfection with the Ssbp3 plasmid,
as evidenced by changes in the cell morphology and the
intensity of alkaline phosphatase (AKP) staining (Fig. 1b).
Our qRT-PCR results showed that the expression levels
of key pluripotency-associated markers such as Oct4,
Sox2, Nanog, and Rex1 were not altered significantly in
ESCs overexpressing Ssbp3 compared with control ESCs
at day 4 (Fig. 1c). However, most trophoblast marker
genes tested, including early TSC markers (Cdx2, Gata3,
Elf5) and relative mature trophoblast markers (Hand1,
Dlx3, Esx1, Psx1, Krt8) [30], were significantly upregu-
lated with greater than 10-fold increases (Fig. 1d), while
most extra-embryonic endoderm marker genes detected
such as Gata6, Gata4, Sox7, and Sox17 were modestly
upregulated about five-fold (Fig. 1e). Meanwhile, expres-
sion levels of germ layer markers (the endoderm, meso-
derm, and ectoderm) displayed mild alterations with less
than two-fold changes (Fig. 1e, f and g). Consistently,
immunofluorescence staining and Western blotting re-
sults revealed the enhanced expression of Cdx2 at the
protein level 96 h after overexpression of Ssbp3 (Fig. 1h
and i). We then evaluated the effect of Ssbp3 on ESCs
under a differentiation condition induced by LIF with-
drawal. Consistent with the results obtained under the
self-renewal condition, trophoblast marker genes were
dramatically upregulated (Figure S1A in Additional file
2). Overexpression of Ssbp3 also elevated extra-
embryonic endoderm markers modestly (Figure S1B in
Additional file 2) with slight alterations in the expression
levels of germ layer-specific and pluripotency markers
(Figure S1B, C, D and E in Additional file 2). These re-
sults implied that overexpression of Ssbp3 could induce
mouse ESC differentiation biased towards trophoblast-
like lineages.
Ssbp3 protein contains three different regions respon-
sible for different functions: a well-conserved FOR-
WARD/LUFS domain at the N-terminal end, through
which Ssbp3 interacts with other proteins; a highly con-
served proline-rich sequence in the middle critical for
embryonic head development; and a C-terminal end
possessing transcriptional activity [14, 31, 32]. To deter-
mine which region conferred Ssbp3 the ability to induce
ESC differentiation, truncation mutants lacking the C-
terminal, or middle, or N-terminal region were con-
structed (Fig. 1j) and transfected into ESCs, respectively.
Unexpectedly, none of the truncation mutants displayed
the same ESC differentiation function as did the full
length Ssbp3 (Fig. 1k). Therefore, it is likely that the ef-
fect of Ssbp3 for inducing ESC differentiation requires
its intact structure.
We next compared gene expression changes induced
by Ssbp3 and Cdx2 overexpression, as Cdx2 is known as
a key regulator for the trophoblast development, and
overexpression of Cdx2 in mouse ESCs has been shown
to efficiently induce trophoblast differentiation [7]. Our
qRT-PCR results showed that expression patterns of
various lineage markers in ESCs overexpressing Ssbp3
resembled those in ESCs overexpressing Cdx2 (Fig. 1l),
suggesting that Ssbp3 might have a role similar to Cdx2
for induction of ESC differentiation. Moreover, we found
that both mRNA and protein levels of Ssbp3 were sub-
stantially higher in TSCs than in ESCs, further support-
ing the association of Ssbp3 with trophoblast lineages at
both mRNA and protein levels (Fig. 1m, n).
Ssbp3 depletion attenuates the activation of trophoblast
gene expression induced by downregulation of Oct4 in
mouse ESCs
Mouse ESCs are usually considered to have a weak abil-
ity, if any, to generate trophoblast cell types by spontan-
eous differentiation [33]. However, genetic manipulation
such as reduction of Oct4 or Tet1 [29, 34], or induction
of Cdx2, Gata3, Arid3a, Brog5, or other key trophoblast-
associated factors, can convert mouse ESCs to TS-like
cells [6, 7, 35–38]. Here, we used the ZHBTc4 mouse
ESC line as an in vitro differentiation model for tropho-
blast induction as previously reported [34]. In this cell
line, both alleles of endogenous Oct4 loci were deleted
and Oct4 expression was controlled by a tetracycline
(Tc)-regulated Oct4 transgene.
In line with published results, Tc treatment reduced
Oct4 expression rapidly at both the mRNA and protein
levels, and robustly induced trophoblast differentiation
(Fig. 2a, b, c). We found that the expression of Ssbp3 at
the mRNA and protein levels increased gradually with
Tc treatment (Fig. 2b, c), adding more evidence for the
potential association of Ssbp3 expression with tropho-
blast differentiation.
To determine whether Ssbp3 plays a role in the
trophoblast differentiation induced by Oct4 downregula-
tion, two shRNA sequences (shSsbp3-976 and shSsbp3-
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1304) targeting different Ssbp3 coding sequences were
used to establish two stable Ssbp3 knockdown ZHBTc4
ESC lines. A control cell line (shNT) was generated
using a non-targeting shRNA sequence (Fig. 2d). qRT-
PCR results showed that Tc treatment for 96 h induced
expression of trophoblast lineage markers in shNT cells
as reported previously [34]. However, levels of these
trophoblast markers were markedly lower in shSsbp3-
976 and shSsbp3-1304 cells than in control cells, al-
though they were still higher than those in ESCs in the
absence of Tc treatment (Fig. 2e). Hence, Ssbp3 was par-
tially required for activation of trophoblast marker genes
induced by Oct4 depletion.
Ssbp3 depletion weakens the trophoblast gene
expression induced by BMP4 and bFGF treatment in ESCs
To determine the role of Ssbp3 in an additional tropho-
blast differentiation model, we developed a new
cytokine-induced trophoblast differentiation protocol
based on two published protocols. One protocol was de-
veloped in Hubert Schorle’s laboratory using a chem-
ically defined TX medium containing bFGF and TGF-β
[23]; the other protocol used BMP4 to enable mouse
ESCs to differentiate into trophoblasts in defined culture
conditions [39]. In this study, we used BMP4 to replace
TGF-β in the TX medium and named the new medium
the Bb medium, as we found that the combination of
Fig. 2 Ssbp3 depletion attenuates the activation of trophoblast gene expression induced by downregulation of Oct4 in mouse ESCs. a The
morphology of ZHBTc4 cells after treatment with Tc. Differentiation was triggered by Tc-mediated downregulation of Oct4. b Expression levels of
Ssbp3 during differentiation of the ZHBTc4 cell line were determined by qRT-PCR analysis. The average mRNA level in ZHBTc4 cells cultured without
Tc was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. c Protein levels of Ssbp3 and Oct4 during ZHBTc4 cell differentiation were
determined by Western blotting. d Western blot analysis of the silencing efficiency of shRNAs targeting the Ssbp3 coding sequence in ZHBTc4 cells. e
The expression levels of trophoblast-specific markers in cells expressing NT control shRNA or specific Ssbp3-targeting shRNA were determined by
qRT-PCR analysis. Expression of Oct4 was downregulated by treatment with Tc for 96 h in ZHBTc4 ESCs. The average mRNA level in shNT-expressing
ZHBTc4 cells cultured in the absence of Tc was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. NT non-targeting, shRNA
short-hairpin RNA, Tc tetracycline
(See figure on previous page.)
Fig. 1 Forced expression of Ssbp3 induces differentiation of mouse ESCs with a trophoblast-like gene expression pattern. a Western blotting of
Ssbp3 protein levels in ESCs transfected with a vector, or an Ssbp3 plasmid. Twenty-four hours after transfection, ESCs were selected by puromycin for
an additional 72 h. b Morphology changes and AKP staining of ESCs overexpressing Ssbp3. c–g Expression levels of pluripotency and lineage markers
in ESCs overexpressing Ssbp3 determined by qRT-PCR analyses. Pluripotency markers (c), trophoblast markers (d), primitive endoderm and endoderm
markers (e), mesoderm markers (f), and ectoderm markers (g). The average mRNA level in cells transfected with the control vector was set at 1.0. Data
are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. h Immunofluorescence staining of ESCs 96 h after transfection. Samples were stained with
anti-Cdx2 (red) antibody, and DAPI staining highlighted the nuclei (blue). i Western blotting of Cdx2 protein levels in ESCs 96 h after transfection.
β-Tubulin was used as an internal control. j The schematic diagram of the Ssbp3 coding sequence and various truncation mutants. k qRT-PCR analysis
for the expression levels of trophoblast markers in ESCs 96 h after transfection of plasmids as indicated. The average mRNA level in cells transfected
with the control vector was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. l qRT-PCR analysis for mRNA levels of pluripotency
and lineage markers 96 h after transfection of indicated plasmids. The average mRNA level in cells transfected with the control vector was set at 1.0.
Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. m, n The mRNA and protein levels of Ssbp3 in ESCs and TSCs determined by qRT-PCR (m)
and Western blotting (n). ESC embryonic stem cell, OE overexpression, TSC trophoblast stem cell
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BMP4 and bFGF in the TX medium could model ESC
differentiation into trophoblast lineages more efficiently.
Cells lost typical ESC morphology and became flat 2 days
after they were cultured in the Bb medium. The majority
of the cells became cobblestone-shaped at day 6 (Fig. 3a).
Transcript levels of Cdx2 and Ssbp3 increased gradually
during the differentiation (Fig. 3b).
To investigate the role of Ssbp3 in this triggering
agent-induced trophoblast differentiation model, we
established two Ssbp3 stable knockdown E14T lines
using the same shRNA sequences mentioned above
(Fig. 3c); a control line was generated with the shNT
sequence. At day 4 of the Bb medium-induced differenti-
ation, the expression of trophoblast transcription factors
(Dlx3, Gata3, Psx1, Esx1, and Hand1) were evidently up-
regulated, with elevated levels ranging from 15-fold to
several hundred-fold compared with levels in undifferen-
tiated ESCs (Fig. 3e–i), further validating that the newly
developed protocol could robustly induce trophoblast
differentiation in ESCs. In accordance with the results
obtained in the Oct4 reduction-induced trophoblast dif-
ferentiation model, depletion of Ssbp3 attenuated the in-
duction of most trophoblast markers significantly
(Fig. 3d–i), supporting the hypothesis that Ssbp3 plays
Fig. 3 Ssbp3 depletion weakens the trophoblast gene expression induced by BMP4 and bFGF treatment in ESCs. a The morphology of E14T cells
after treatment with bone BMP4 and bFGF at the indicated time points. b Expression levels of Ssbp3 gradually increased in E14T cells treated
with BMP4 and bFGF. The expression levels of Ssbp3 were determined by qRT-PCR analysis. The average mRNA level in E14T cells cultured
without treatment was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. c The silencing efficiency of shRNAs targeting Ssbp3
in E14T cells was detected by qRT-PCR analysis at day 4. d–i The expression levels of trophoblast-specific markers in cells expressing NT control
shRNA or specific Ssbp3-targeting shRNAs were determined by qRT-PCR analysis. E14T cells were induced to trophoblast differentiation by
treatment with BMP4 and bFGF for 96 h. The average mRNA level in shNT-expressing E14T cells without treatment was set at 1.0. Data are shown
as mean ± SD (n = 3). *p < 0.05, **p < 0.01. bFGF basic fibroblast growth factor, BMP4 bone morphogenetic protein 4, NT non-targeting, shRNA
short-hairpin RNA
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an important role for the full induction of trophoblast
lineage markers during ESC differentiation into trophoblast-
like cells.
Overexpression of Ssbp3 induces a trophoblast-like
transcriptional program
To investigate the transcriptional effect of ectopic expres-
sion of Ssbp3 on a genome-wide scale, we compared the
global transcriptional profile of Ssbp3-overexpressing cells
with that of control cells using affymetrix microarray. Bio-
logical duplicate samples were used in this assay. One
thousand eight hundred and eighty differentially expressed
genes (DEG) were identified with a cutoff threshold of
two-fold, including 980 upregulated and 900 downregu-
lated genes, respectively (Fig. 4a, left panel; Table S2 in
Additional file 3). The top 30 DEGs induced were listed in
the heatmap shown in the right panel of Fig. 4a. As antici-
pated, the majority of the listed top genes are specifically
related to the trophoblast development. Notably, critical
TSC master regulators such as Cdx2, Elf5 and Gata3 were
included in the list. The findings suggested that ectopic
expression of Ssbp3 evoked an overall startup of a
trophoblast-like transcriptional program in mouse ESCs.
To further define the ability of Ssbp3 to induce ESC
differentiation to a trophoblast-like phenotype, we com-
pared the global expression profile of Ssbp3-overexpressing
ESCs with previously published profiles of Cdx2- and
Gata3-overexpressing ESCs [6]. As shown, 60.1 % (1141
out of the 1880) of the DEGs induced by Ssbp3 were
shared with the DEGs induced by Cdx2 or Gata3 (Fig. 4b;
Table S3 in Additional file 4). GO analysis illustrated that
these overlapped genes were strongly enriched in terms
associated with transcription regulation and placenta de-
velopment (Fig. 4c). Moreover, we analyzed the upregu-
lated genes in Ssbp3-overexpressing cells using a batch
query tool at the website of the Mouse Genome Informat-
ics (MGI). Recovered mammalian phenotype (MP) terms
contained multiple trophoblast subtypes and developmen-
tal stages (Table S4 in Additional file 5), similar to the MP
terms recovered in Cdx2- and Gata3-overexpressing cells
[6]. These results further validated the role of Ssbp3 for
inducing a trophoblast-like transcriptional program in
mouse ESCs. In addition, the remaining 39.9 % (739 out
of the 1880) of the DEGs specifically induced by Ssbp3
(Fig. 4b; Table S3 in Additional file 4) were also analyzed
by GO analysis, and they were most enriched in terms re-
lated to skeletal system development and morphogenesis
(Figure S2 in Additional file 6), well in accordance with
the previously reported phenotype of truncation of anter-
ior skull bones and mild skeletal defects in other body
parts in Ssbp3 knockout mice [13, 14].
Since TS-specific master genes Cdx2 and Elf5 were
listed among the top 20 upregulated genes induced by
overexpression of Ssbp3, we were interested to know
whether Cdx2 or Elf5 acted as the downstream factors
of Ssbp3, and were therefore involved in the
trophoblast-like differentiation program from ESCs
driven by exogenous expression of Ssbp3. To address
this question, shRNAs based Cdx2 or Elf5 stable knock-
down ESC lines were established. The results of qRT-
PCR analyses revealed that knockdown of either Cdx2
or Elf5 obviously compromised the ability of Ssbp3 to
induce the expression of trophoblast marker genes
(Fig. 4d, e), indicating that Cdx2 and Elf5 probably play
important roles for Ssbp3 to drive the trophoblast-like
transcription program from ESCs.
Overexpression of Ssbp3 decreases the methylation level
at the Elf5 promoter in mouse ESCs
The methylation status of the Elf5 promoter was re-
ported to have a robust difference between ESCs and
TSCs [40, 41], with a methylated and repressive status in
ESCs and a hypo-methylated and active status in TSCs.
We compared the methylation status at four separate re-
gions of the Elf5 promoter positioning from –1000 bp to
+400 bp with respect to the transcription start site (TSS)
among ESCs overexpressing Ssbp3 at day 6, undifferenti-
ated ESCs, and TSCs. Bisulfite sequencing analysis
showed that all regions were extensively methylated in
undifferentiated ESCs but hypo-methylated in TSCs.
However, in Ssbp3-overexpressing ESCs, the percentage
of methylated CpG dinucleotides was higher in all four
regions compared to TSCs, but lower in regions 2, 3 and
4 compared to undifferentiated ESCs (Fig. 5). Thus, it
seems that overexpression of Ssbp3 in ESCs under a
self-renewal culture condition generated a specific Elf5
promoter methylation pattern in which the methylation
level was between undifferentiated ESCs and TSCs, in
line with the elevated Elf5 mRNA level in Ssbp3-
overexpressing ESCs.
Ssbp3 overexpression activates MAPK/Erk1/2 and TGF-β
pathways
Trophoblast differentiation involves multiple signaling
pathways. We examined which pathway was activated
upon Ssbp3 overexpression. KEGG pathway analysis of
all 1880 DEGs induced by Ssbp3 overexpression showed
that MAPK/Erk1/2 signaling and TGF-β signaling path-
ways were markedly enriched (Fig. 6a). These two path-
ways had been previously reported to be critical for
establishment of the trophectoderm in vivo or mainten-
ance of TSC proliferation in vitro [18, 20]. Our qRT-
PCR analysis for these signaling-related components
verified their activation in Ssbp3-overexpressing cells
(Fig. 6b, c). Besides, Western blotting showed enhanced
phosphorylation levels of Erk1/2 in Ssbp3-overexpressing
cells, suggesting a possible interplay between Ssbp3
and the MAPK/Erk1/2 pathway (Fig. 6d). Functionally,
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Fig. 4 (See legend on next page.)
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treatment of Ssbp3-overexpressing ESCs with a MAP
kinase-ERK kinase (MEK) inhibitor, PD0325901 [42],
diminished the upregulation of Cdx2 induced by Ssbp3
overexpression (Fig. 6e). The result was consistent with
the report that PD0325901 treatment impaired Cdx2
expression and function in early embryos [18]. Taken
together, these data indicated that Ssbp3 could activate
MAPK/Erk1/2 and TGF-β pathways, which might be,
at least partially, responsible for the activation of the
trophoblast lineage marker genes induced by Ssbp3
overexpression.
Teratomas derived from Ssbp3-overexpressing ESCs
contain hemorrhage
To test the developmental potential of Ssbp3-overexpressing
ESCs in vivo, ESCs transfected with the Ssbp3 expression
plasmid were intramuscularly injected into NOD/SCID
mice. ESCs transfected with an empty vector were injected
as a negative control. Teratomas were obtained from these
mice 6 weeks later. Three teratomas were generated from
vector-transfected ESCs and 10 teratomas were generated
from Ssbp3-overexpressing ESCs (Fig. 7a). Teratomas
generated from Ssbp3-overexpressing ESCs were larger
and heavier compared with teratomas derived from con-
trol ESCs (Fig. 7a and b). Of note, Ssbp3-overexpressing
ESC-produced teratomas contained obvious hemorrhage.
Histologically, both types of teratomas contained tissues
and cells representing all three embryonic germ layers
(Fig. 7c and d). However, clusters of trophoblast giant cells
possessing large cytoplasm and large nuclei could be ap-
parently observed in the internal hemorrhagic regions of
Ssbp3-overexpressing ESC-produced teratomas, but not
in control ESC-generated teratomas (Fig. 7e). Further-
more, expression levels of trophoblast markers were much
higher in teratomas derived from Ssbp3-overexpressing
ESCs compared with control teratomas (Fig. 7f ).
Therefore, overexpression of Ssbp3 aroused the ten-
dency of ESCs to differentiate into trophoblast-like cell
types in vivo.
ESCs overexpressing Ssbp3 mainly contribute to the
placenta part in chimeric embryos
To study the in vivo differentiation ability of ESCs over-
expressing Ssbp3, we injected mouse ESCs genetically
labeled with green fluorescent protein (GFP) and overex-
pressing Ssbp3 into 8-cell-stage embryos (E2.5) and
(See figure on previous page.)
Fig. 4 Overexpression of Ssbp3 induces a trophoblast-like transcriptional program. a Heatmap of the DEGs induced by Ssbp3 overexpression in
ESCs (fold change >2). Green and red values represent fold changes for down- and upregulation, respectively. Heatmap in the right panel shows
the top 30 upregulated genes in detail. b Venn diagram showing the overlap of the DEGs induced by Ssbp3 (green), Gata3 (blue), or Cdx2 (orange)
overexpression, with the number of genes indicated. Out of 1880 DEGs induced by Ssbp3, 1141 DEGs were shared with Gata3 or Cdx2. c Significantly
enriched GO terms of the 1141 DEGs shared between Ssbp3 and Cdx2 or between Ssbp3 and Gata3. d, e qRT-PCR analysis for expression levels of
trophoblast-specific markers in Cdx2 and Elf5 stable knockdown cell lines 96 h after Ssbp3 overexpression. The average mRNA level in stable cell line
expressing shNT was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. GO gene ontology, NT non-targeting, OE overexpression,
shRNA short-hairpin RNA
Fig. 5 Overexpression of Ssbp3 decreases the methylation level at the Elf5 promoter in mouse ESCs. Clonal bisulfite sequencing of the 1 kb
promoter region of Elf5 in ESCs, TSCs, and ESCs overexpressing Ssbp3 were shown. Each line represents an individual clone with open circles
depicting unmethylated sites and filled circles indicating methylated sites. The CpG dinucleotide at –355 bp is polymorphic and absent where
shaded gray. ESC embryonic stem cell, TSC trophoblast stem cell
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traced their distribution at E6.5 and E14.5, respectively
(Figure S3A in Additional file 7). We carried out two
batches of experiments. In the first batch of experiment,
we injected 30 embryos with control cells overexpressing
a vector and 50 embryos with ESCs overexpressing
Ssbp3. At E6.5, one embryo injected with the control
ESCs and nine embryos injected with ESCs overexpress-
ing Ssbp3 were obtained. In contrast to the whole em-
bryo distribution of vector-transfected ESCs, in six out
of nine embryos, ESCs overexpressing Ssbp3 were lo-
cated predominantly in the trophoblast giant cell region
and ectoplacental cone, as well as in extra-embryonic
endoderm, but not in the epiblast of E6.5 embryos
(Figure S3B in Additional file 7). In the second batch of
experiments, we injected 50 embryos with control cells
and 50 embryos with Ssbp3-overexpressing ESCs. At
E14.5, out of 100 injected embryos, only one embryo
injected with Ssbp3-overexpressing ESCs was obtained.
Consistent with the result obtained in the first batch of
experiments, the Ssbp3-overexpressing ESCs mainly
contributed to the placenta part (Figure S3C in
Additional file 7). These data suggest an active role of
Ssbp3 for promoting trophoblast-like lineage differenti-
ation in vivo.
Discussion
The present study shows that Ssbp3 might be an import-
ant regulator of trophoblast lineage differentiation. The
following lines of experimental evidence support this
proposal: i) Ssbp3 was highly expressed in TSCs, and its
expression gradually increased during ESC trophoblast
differentiation induced by Oct4 knockdown or treatment
with BMP4 and bFGF; ii) overexpression of Ssbp3 dra-
matically induced the expression of trophoblast marker
genes; iii) depletion of Ssbp3 attenuated the induction of
trophoblast-associated genes induced by downregulation
of Oct4 or treatment with BMP4 and bFGF in ESCs; iv)
Ssbp3-overexpressing ESCs generated large aggressive
teratomas with massive internal hemorrhage in vivo; and
v) when injected into 8-cell-stage embryos, Ssbp3-
overexpressing ESCs mainly contributed to the placenta
part. Interestingly, downregulation of Ssbp3 decreased
the induction of Cdx2 and Esx1 more dramatically than
other trophoblast marker genes when Oct4 was down-
regulated or when BMP4 and bFGF were included in the
ESC culture medium. It is possible that Ssbp3, as a DNA
binding protein, regulates Cdx2 and Esx1 directly, al-
though we do not have any experimental evidence
for this.
Our global gene expression analysis revealed that
Ssbp3 could drive a trophoblast-like transcriptional pro-
gram in ESCs. About 60 % of the 1880 DEGs induced by
Ssbp3 overexpression overlapped with the previously re-
ported DEGs induced by Cdx2 or Gata3 [6], indicating
that these three regulators may share functional mecha-
nisms to drive trophoblast differentiation. GO analysis
Fig. 6 Ssbp3 overexpression activates MAPK/Erk1/2 and TGF-β pathways. a Significantly enriched signaling pathways of all DEGs upon overexpression
of Ssbp3 by KEGG pathway analysis. b, c qRT-PCR analysis for expression levels of upregulated genes related to MAPK/Erk/1/2 and TGF-β pathways in
Ssbp3-overexpressing ESCs. The average mRNA level in cells transfected with the control vector was set at 1.0. Data are shown as mean ± SD (n = 3).
*p < 0.05, **p < 0.01. d Western blotting of p-Erk1/2 and total Erk1/2 protein levels in Ssbp3-overexpressing cells. Cells transfected with an Ssbp3
plasmid or a vector were collected at 48 h and 96 h after transfection, respectively. e qRT-PCR analysis for expression levels of Cdx2 in
Ssbp3-overexpressing ESCs with or without PD0325901 treatment. The average mRNA level in cells transfected with the control vector in the absence
of PD0325901 was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. Erk extracellular signal-regulated kinase, MAPK
mitogen-activated protein kinase, OE overexpression, TGF transforming growth factor
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Fig. 7 Teratomas derived from Ssbp3-overexpressing ESCs contain hemorrhage. a Gross appearance of teratomas derived from control cells or
Ssbp3-overexpressing ESCs (upper panel). The number of teratomas examined is presented in the table (lower panel). b The net weight of
teratomas derived from control cells and Ssbp3-overexpressing ESCs. c Cross-section of teratomas derived from control cells (upper panel) or
Ssbp3-overexpressing ESCs (lower panel). d Histology of teratomas derived from control cells (upper panel) or Ssbp3-overexpressing ESCs
(lower panel) showing tissue complexity (hematoxylin and eosin staining). Arrowheads mark the endoderm (black), mesoderm (blue), and ectoderm
(green) cells. e Hematoxylin and eosin-stained images for sections of a teratoma derived from Ssbp3-overexpressing ESCs. The trophoblast cluster
(arrow heads, left panel) and trophoblast giant cells with the enlarged nuclei (arrow heads, right panel) are indicated. f qRT-PCR analysis for expression
levels of trophoblast-specific markers in teratomas derived from control cells or Ssbp3-overexpressing ESCs. The average mRNA level in teratomas
derived from control cells was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01. OE overexpression
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illustrated that the DEGs shared by Ssbp3 and Cdx2 or
Ssbp3 and Gata3 were highly enriched in terms associated
with transcription regulation and placenta development.
Cdx2 and Elf5, two key regulators of TSC self-renewal
and maintenance, were robustly induced by ectopic ex-
pression of Ssbp3. Notably, Cdx2 or Elf5 depletion im-
paired activation of trophoblast lineage marker genes
induced by Ssbp3 overexpression. These findings imply
that Ssbp3 may act as an upstream regulator for the ex-
pression of Cdx2 and Elf5 during trophoblast differenti-
ation, although it is not clear whether Ssbp3 executes this
function directly or not. Although Ssbp3, Cdx2, and Gata3
can all activate trophoblast lineage marker genes, each has
its distinct targets. In fact, GO analysis demonstrates that
the specific DEGs regulated by Ssbp3 are strongly related
to embryonic skeletal system development and the pattern
specification process, indicating that Ssbp3 plays a role in
embryogenesis as previously reported [13, 14]. Further-
more, KEGG analysis showed that MAPK/Erk1/2 and
TGF-β pathways were activated in Ssbp3-overexpressing
ESCs. All of the bioinformatic analyses, including GO,
KEGG, and MP, support the hypothesis that Ssbp3 is
closely associated with the transcriptional regulatory cir-
cuitry of trophoblast cell differentiation. As Ssbp3 was
highly expressed in TSCs and activated transcription fac-
tors and signaling pathways required for TSC self-renewal,
we propose that Ssbp3 may function at, or from, an early
stage of trophoblast lineage specification.
The detailed mechanism by which Ssbp3 executed its
function in regulation of trophoblast gene expression is
not clear yet. Based on the facts that the overlapped
DEGs between Ssbp3 and Cdx2 or Ssbp3 and Gata3
were strongly enriched in terms associated with tran-
scriptional regulation and that Ssbp3 was reported to
have transcriptional activity in its C-terminus [32], we
anticipate that it may function through regulating gene
expression as a transcription factor. However, where and
how it binds the genome remains unclear. In fact, Ssbp3
binding sites, including both single- and double-
stranded DNAs, are still rarely identified. So far only a
pyrimidine-rich element in the promoter region of the
chicken α2 (I) collagen gene was identified as a single-
stranded DNA binding site by Ssbp3 [10]. Further inves-
tigations with chromatin immunoprecipitation coupled
with DNA-sequencing (ChIP-seq) assays may help to ad-
dress this question.
Our study shows that Ssbp3 plays an important role
during trophoblast lineage specification in vitro.
However, previous studies reported that Ssbp3 null
mice showed skeletal abnormalities, but nothing was
mentioned about placental abnormalities or embry-
onic lethality [11, 12]. The lack of early embryonic
lethality (at or before implantation) in Ssbp3 knock-
out mice might be explained by functional
redundancy from other family members. Supporting
this hypothesis, we found that Ssbp2, another member
of the Ssbp3 family, had a similar role to Ssbp3. Over-
expression of Ssbp2 changed ESC morphology and led
to increased expression of trophoblast-associated
markers to an extent more dramatic than other lineage
markers (data not shown). Therefore, double-knockout
of Ssbp3 and Ssbp2 in mice could be helpful to verify
the assumption.
It is known that Ssbp3 plays a critical role in the head
morphogenesis during mouse embryonic development
through activating the Lim1-Ldb1 transcriptional com-
plex via interaction with Ldb1 [13]. To explore the effect
of Ldb1 on the induction of trophoblast marker gene
expression induced by Ssbp3, we up- and downregu-
lated Ldb1 in ESCs together with Ssbp3 overexpres-
sion, respectively. No obvious effects were found (data
not shown), suggesting that the trophoblastic gene in-
duction activity of Ssbp3 may be Ldb1-independent.
Further exploration of proteins interacting with Ssbp3
will facilitate our understanding of how Ssbp3 controls
the trophoblast-like transcriptional program and acti-
vates related pathways.
Conclusions
Ectopic expression of Ssbp3 robustly induced tropho-
blast lineage marker gene expression in mouse ESCs.
Conversely, depletion of Ssbp3 attenuated the tropho-
blast gene activation. Ssbp3 controlled a trophoblast-like
transcriptional program by inducing the expression of
early trophectoderm master transcription factors such as
Cdx2, Gata3, and Elf5, and by activating MAPK/Erk1/2
and TGF-β pathways, two signaling pathways essential
for trophoblast development. Both gain- and loss-of-
function experiments support the notion that Ssbp3
might be an important regulator involved in trophoblast
differentiation from mouse ESCs. The study is significant
for better understanding the regulatory networks con-
trolling ESC differentiation into extra-embryonic line-
ages and should shed light on the study of trophoblast
development of mouse early embryos.
Additional files
Additional file 1: Table S1. Primers used in this study for gene cloning,
qRT-PCR, and shRNA targeting sequences. (XLSX 16 kb)
Additional file 2: Figure S1. Forced expression of Ssbp3 induces
mouse ESC differentiation with a bias to trophoblast lineages under the
LIF withdrawal condition. (A–E) Expression levels of pluripotency and
lineage specific markers in ESCs overexpressing Ssbp3 were determined
by qRT-PCR analyses, including markers for the trophoblast (A), primitive
and definitive endoderm (B), mesoderm (C), ectoderm (D), and pluripotency
(E). The average mRNA level in cells transfected with the control vector
was set at 1.0. Data are shown as mean ± SD (n = 3). *p < 0.05, **p < 0.01.
(TIF 306 kb)
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Additional file 3: Table S2. Differentially expressed genes induced by
Ssbp3. (XLSX 36 kb)
Additional file 4: Table S3. Shared or specific DEGs induced by Ssbp3,
Cdx2, or Gata3 overexpression. (XLSX 110 kb)
Additional file 5: Table S4. MGI Batch Report—mammalian phenotype
(MP) ontology of the upregulated genes induced by Ssbp3
overexpression. (XLSX 15 kb)
Additional file 6: Figure S2. GO analysis of 739 Ssbp3 specific genes
compared with DEGs induced by Gata3 or Cdx2 overexpression. The
significantly enriched GO terms are strongly related to embryonic
skeletal system development and pattern specification process.
(TIF 78 kb)
Additional file 7: Figure S3. Ssbp3-overexpressing ESCs mainly
contribute to the placenta part in chimeric embryos. (A) GFP-labeled
E14T cells overexpressing a vector or an Ssbp3 expression plasmid
were injected into wild-type 8-cell-stage embryos. For each embryo,
two GFP-labeled cells were injected. (B) Strong contribution of
injected E14T cells overexpressing Ssbp3 to the extra-embryonic
lineage in E6.5 chimeric embryos. Gross and fluorescence images of
E6.5 chimeric embryos developed from embryos described in A. (C)
E14T cells overexpressing Ssbp3 predominantly contributed to the
placenta part of the E14.5 chimeric embryo. (TIF 7678 kb)
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